Lonza CellBio Services is pleased to announce the global availability of cryopreserved leukopaks for research use only applications. The cryopreserved leukopaks are manufactured from peripheral blood of normal human donors at a facility in the United States. Each cryopreserved leukopak consists of a concentrated fraction of mononuclear cells including B cells, T cells, NK cells, dendritic cells, monocytes, etc. produced by leukapheresis. All cells are obtained using IRB approved consent forms and protocols from a pool of 1000+ recallable donors:
Product Features Include:
- Viral Testing: HIV, HBV, HCV (within 90 days of donation)
- HLA typed via 6-digit NGS
- Viability: >95%
- Multiple product Sizes:
- 9.5 billion cells
- 5.0 billion cells
- 2.5 billion cells
Cyro Leukopaks are frozen within 2 hours after collection using a controlled rate method to maximize viability. Our post-thaw viability is industry leading, consistently achieving >95% viability.
Cryopreserved leukopaks are cryopreserved in a CS1000 bag and shipped on dry ice for next day delivery in North America, and expedited delivery to Europe (typically within 48-72 hours)
Custom sizes/formats/donor requirements are available upon request.
Upon arrival, the customer should store the frozen LeukoPak in Vapor Phase Nitrogen
For more information or a quote, please contact Lonza CellBio Services (cellbioservices@lonza.com)